Group News

The Heartmate III system
NYP/Columbia is one of the leading centers in the world for patients with end-stage heart disease, and one of the first to allow those with end-stage heart failure to benefit from Heartmate 3. This new left ventricle assist device (LVAD) takes over the pumping action of the heart, moving oxygen-rich blood throughout the body.
Read More >
In December 2016, a retrospective study from the Mayo Clinic indicated that a surgeon can safely be responsible for two overlapping procedures when critical parts of the procedures are not coincident. The study of overlapping operations showed no difference in patient outcomes, but increased effectiveness and time management. Paul Kurlansky, MD, Associate Director of Columbia’s Center for Innovation and Outcomes Research at NYP/Columbia, stresses that there is a big difference between overlapping and concurrent operations. With overlapping procedures, "surgeons cannot be booked to perform critical parts of two operations at the same time," he said. Craig Smith, MD, surgeon-in-chief, NYP/Columbia told Medscape Medical News has been performing overlapping operations routinely for more than 30 years, and he believes his judgment should be trusted with regard to when and how to do them.
Read More >
A recent study published in Circulation shows that patients who take their medication faithfully have dramatically better long-term outcomes, regardless of whether they have CABG or PCI. However, among the non-adherent group, CABG patients fared better with fewer major adverse cardiac events in the years after surgery. “This study shows how important it is to get to know your patients and find out how well they comply with medication,” says Paul Kurlansky, MD, who led the study and is currently director of research for Columbia HeartSource.
Read More >
NYP/Columbia was among the first to offer patients access to Heartmate 3, the newest LVAD technology, in a clinical trial testing it against current standard of treatment, the Heart Mate II. In a randomized study reported in New England Journal of Medicine and presented at American Heart Association in November 2016, lead investigator Yoshifumi Naka, MD, PhD, reported fewer complications with the Heartmate 3, noting a marked improvement over Heartmate II.
Read More >
What's New in the Department of Surgery

Mini-Sternotomy for a Tortuous Aortic Aneurysm

Read More >
What's New in the Department of Surgery

Pulmonary Vein Stenosis (PVS)

Read More >
The Structural Heart and Valve Center at NYP/Columbia has long been a leader in catheter-based treatment—the least invasive therapy—to repair the mitral valve. This valve regulates blood flow between the upper and the lower chambers on the left side of the heart. When it is damaged or defective, blood flows back up into the upper chamber, producing Mitral Regurgitation (MR).
Read More >

Pages